IL158485A0 - Spiropyrazole compounds - Google Patents

Spiropyrazole compounds

Info

Publication number
IL158485A0
IL158485A0 IL15848502A IL15848502A IL158485A0 IL 158485 A0 IL158485 A0 IL 158485A0 IL 15848502 A IL15848502 A IL 15848502A IL 15848502 A IL15848502 A IL 15848502A IL 158485 A0 IL158485 A0 IL 158485A0
Authority
IL
Israel
Prior art keywords
spiropyrazole
compounds
spiropyrazole compounds
whereinz
compound
Prior art date
Application number
IL15848502A
Other languages
English (en)
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of IL158485A0 publication Critical patent/IL158485A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Dental Preparations (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IL15848502A 2001-04-18 2002-04-18 Spiropyrazole compounds IL158485A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28467501P 2001-04-18 2001-04-18
PCT/US2002/012376 WO2002085355A1 (en) 2001-04-18 2002-04-18 Spiropyrazole compounds

Publications (1)

Publication Number Publication Date
IL158485A0 true IL158485A0 (en) 2004-05-12

Family

ID=23091099

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15848502A IL158485A0 (en) 2001-04-18 2002-04-18 Spiropyrazole compounds
IL158485A IL158485A (en) 2001-04-18 2003-10-19 Spiropyrazole compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158485A IL158485A (en) 2001-04-18 2003-10-19 Spiropyrazole compounds

Country Status (28)

Country Link
US (2) US6635653B2 (xx)
EP (1) EP1385515B1 (xx)
JP (1) JP4342181B2 (xx)
KR (1) KR100628292B1 (xx)
CN (1) CN1516584A (xx)
AT (1) ATE403429T1 (xx)
AU (1) AU2002311833B2 (xx)
BR (1) BR0209127A (xx)
CA (1) CA2444634C (xx)
CY (1) CY1108454T1 (xx)
CZ (1) CZ20032849A3 (xx)
DE (1) DE60228071D1 (xx)
DK (1) DK1385515T3 (xx)
ES (1) ES2312584T3 (xx)
HK (1) HK1062885A1 (xx)
HU (1) HUP0401333A3 (xx)
IL (2) IL158485A0 (xx)
MX (1) MXPA03009604A (xx)
NO (1) NO20034660L (xx)
NZ (1) NZ528978A (xx)
PL (1) PL367263A1 (xx)
PT (1) PT1385515E (xx)
RU (1) RU2299883C2 (xx)
SI (1) SI1385515T1 (xx)
UA (1) UA74439C2 (xx)
WO (1) WO2002085355A1 (xx)
YU (1) YU82403A (xx)
ZA (1) ZA200308103B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03009604A (es) * 2001-04-18 2004-04-02 Euro Celtique Sa Compuestos de espiropirazol.
PT1491212E (pt) 2002-03-29 2012-11-16 Mitsubishi Tanabe Pharma Corp Medicamento para distúrbios de sono
MXPA05002622A (es) 2002-09-09 2005-09-08 Johnson & Johnson Derivados de 1,3,8,-triazaespiro [4.5]decan-4-ona sustituidos con hidroxialquilo utiles para el tratamiento de desordenes mediados por el receptor opioide huerfano.
JP2006503093A (ja) * 2002-10-17 2006-01-26 ユーロ−セルティーク エス．エイ． トリアゾスピロ化合物の調製
US20040242583A1 (en) * 2003-01-20 2004-12-02 Aventis Pharma Deutschland Gmbh Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use
WO2004103305A2 (en) * 2003-05-16 2004-12-02 Euroceltique S.A. Spiropyrazole compound
WO2005011665A1 (en) * 2003-07-22 2005-02-10 Arakis Ltd. The use of proglumide for the treatment of emesis
US20100028339A1 (en) * 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
EP1737472B1 (en) 2004-03-29 2014-08-13 University Of South Florida Effective treatment of tumors and cancer with triciribine
US20110008327A1 (en) * 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
EA014239B1 (ru) 2005-03-08 2010-10-29 Янссен Фармацевтика Н.В. Производные диаза-спиро-[4,4]нонана в качестве антагонистов нейрокинина (nk1)
CN1870631B (zh) * 2005-11-11 2010-04-14 华为技术有限公司 媒体网关的门控方法
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
MX2009005641A (es) 2006-11-28 2009-06-05 Janssen Pharmaceutica Nv Sales de 3-(3-amino-2-(r)-hidroxi-propil)-1-(4-fluoro-fenil)-8-(8- metil-naftalen-1-ilmetil)-1,3,8-triaza-espiro[4,5]deca n-4-ona.
DE602008002690D1 (de) * 2007-01-16 2010-11-04 Purdue Pharma Lp Heterozyklische substituierte piperidine als orl-1-liganden
CA2683598C (en) 2007-04-09 2015-11-17 Janssen Pharmaceutica Nv 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
RU2488585C2 (ru) 2007-08-31 2013-07-27 Пэдью Фарма Л.П. Замещенные пиперидиновые соединения хиноксалинового типа и их применение
AR072578A1 (es) 2008-07-21 2010-09-08 Purdue Pharma Lp Compuestos de piperidina puenteada tipo quinoxalina sustituida y los usos de los mismos
UA107943C2 (xx) * 2009-11-16 2015-03-10 Lilly Co Eli Сполуки спіропіперидину як антагоністи рецептора orl-1
JP5872585B2 (ja) 2010-12-22 2016-03-01 パーデュー、ファーマ、リミテッド、パートナーシップ リン置換キノキサリンタイプピペリジン化合物とその使用
JP2014533744A (ja) 2011-12-01 2014-12-15 パーデュー、ファーマ、リミテッド、パートナーシップ アゼチジン置換キノキサリンタイプピペリジン化合物とその使用
US9085561B2 (en) 2012-07-30 2015-07-21 Purdue Pharma L.P. Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators
WO2014102589A1 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Quinazolin-4(3h)-one-type piperidine compounds and uses thereof
US10118927B2 (en) 2012-12-27 2018-11-06 Purdue Pharma L.P. Substituted piperidin-4-amino-type compounds and uses thereof
US9090618B2 (en) 2012-12-27 2015-07-28 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
US9963458B2 (en) 2012-12-27 2018-05-08 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US9040533B2 (en) 2012-12-27 2015-05-26 Purdue Pharma L.P. Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators
WO2018023017A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Methods of treating prostate cancer
CN111825681A (zh) * 2020-07-07 2020-10-27 扬州大学 一种合成(e)-亚苄基螺吡唑吡咯嗪酮类化合物的方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB157497A (xx) *
US3161645A (en) 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3318900A (en) 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
US3325499A (en) 1964-11-02 1967-06-13 Mcneilab Inc 1-(1-hydrocarbyl-4-piperdyl)-2-indolinone
US3923993A (en) * 1973-06-28 1975-12-02 American Home Prod Process for treating neuroendocrinopathic diseases employing fluspirilene
DE2609645A1 (de) 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4329353A (en) 1980-10-22 1982-05-11 Janssen Pharmaceutica, N.V. 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
US4410528A (en) 1980-05-16 1983-10-18 Kyowa Hakko Kogyo Co., Ltd. Hypotensive piperidine derivatives
JPS58180481A (ja) 1982-04-15 1983-10-21 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体
JPS60120872A (ja) 1983-12-01 1985-06-28 Kyowa Hakko Kogyo Co Ltd 新規なヘテロ環状化合物及び強心剤
WO1995028397A1 (en) 1994-04-14 1995-10-26 Merck & Co., Inc. Alpha1c adrenergic receptor antagonists
FR2722190B1 (fr) 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
US5767118A (en) 1994-10-26 1998-06-16 Merck & Co., Inc. 4-Heterocyclic peperidines promote release of growth hormone
US5574044A (en) 1994-10-27 1996-11-12 Merck & Co., Inc. Muscarine antagonists
EP0974583B1 (en) 1995-09-13 2002-05-29 Kyowa Hakko Kogyo Co., Ltd. Phenylpiperidine derivatives
ATE341542T1 (de) 1996-04-19 2006-10-15 Neurosearch As 1-(4-piperidyl)-benzimidazole mit neurotropher aktivität
US6063796A (en) 1997-04-04 2000-05-16 Merck & Co., Inc. Somatostatin agonists
CN1258294A (zh) 1997-05-30 2000-06-28 万有制药株式会社 2－氧代咪唑衍生物
JPH10330377A (ja) 1997-06-02 1998-12-15 Kyowa Hakko Kogyo Co Ltd ピペリジン誘導体
US6166037A (en) 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
EP0921125B1 (en) 1997-12-05 2002-01-30 F. Hoffmann-La Roche Ag 1,3,8-Triazaspiro[4,5]decan-4-on derivatives
US6166209A (en) 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
IL137149A0 (en) 1998-01-19 2001-07-24 Pfizer 4-(2-keto-1-benzimidazolinyl) piperidine compounds as orl1-receptor agonists
RU2202344C2 (ru) 1998-03-26 2003-04-20 Джапан Тобакко Инк. Антагонисты ноцицептина, производные амида, аналгетик, способ инициирования антагонистического действия к ноцицептину, способ лечения боли, фармацевтические композиции
AU3809999A (en) 1998-05-18 1999-12-06 Novo Nordisk A/S Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
ID29137A (id) 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
MA26659A1 (fr) 1998-08-06 2004-12-20 Pfizer Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
SE9904652D0 (sv) 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
JP2004531456A (ja) 2000-09-06 2004-10-14 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 置換ピラゾールを用いてアレルギーを治療する方法
MXPA03009604A (es) * 2001-04-18 2004-04-02 Euro Celtique Sa Compuestos de espiropirazol.

Also Published As

Publication number Publication date
UA74439C2 (uk) 2005-12-15
CA2444634C (en) 2011-06-07
CY1108454T1 (el) 2014-04-09
NO20034660D0 (no) 2003-10-17
EP1385515A4 (en) 2004-06-30
CA2444634A1 (en) 2002-10-31
YU82403A (sh) 2006-08-17
IL158485A (en) 2009-09-01
HUP0401333A3 (en) 2004-11-29
RU2299883C2 (ru) 2007-05-27
WO2002085355A1 (en) 2002-10-31
SI1385515T1 (sl) 2008-12-31
ES2312584T3 (es) 2009-03-01
US6635653B2 (en) 2003-10-21
RU2003133455A (ru) 2005-05-10
US20040087641A1 (en) 2004-05-06
EP1385515B1 (en) 2008-08-06
PL367263A1 (en) 2005-02-21
DE60228071D1 (de) 2008-09-18
HUP0401333A2 (hu) 2004-10-28
DK1385515T3 (da) 2008-10-27
JP4342181B2 (ja) 2009-10-14
NO20034660L (no) 2003-12-17
MXPA03009604A (es) 2004-04-02
KR20040008159A (ko) 2004-01-28
US20030027834A1 (en) 2003-02-06
ATE403429T1 (de) 2008-08-15
NZ528978A (en) 2004-06-25
ZA200308103B (en) 2004-10-18
CZ20032849A3 (en) 2004-03-17
CN1516584A (zh) 2004-07-28
JP2004531531A (ja) 2004-10-14
BR0209127A (pt) 2006-03-21
KR100628292B1 (ko) 2006-09-27
AU2002311833B2 (en) 2005-04-28
HK1062885A1 (en) 2004-12-03
EP1385515A1 (en) 2004-02-04
PT1385515E (pt) 2008-09-15

Similar Documents

Publication Publication Date Title
IL158485A0 (en) Spiropyrazole compounds
YU82303A (sh) Analozi nociceptina
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
MY126559A (en) Fungicidal 2-methoxybenzophenones
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
DE60229736D1 (de) Spiroinden- und spiroindan-verbindungen
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
DE60214392D1 (de) 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
GB0124627D0 (en) Novel compounds
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
MXPA03009602A (es) Analogos de nociceptina.
SE0004245D0 (sv) Novel compounds and their use
SI1975164T1 (sl) Oktahidrobenzimidazolonske spojine kot analgetiki
AU2003268342A8 (en) Antimicrobial compositions
EP1671948A4 (en) CINNAMOYL COMPOUND AND USE THEREOF
EP1671961A4 (en) CINNAMOYL COMPOUND AND USE THEREOF
MXPA05006450A (es) Nuevo derivado de 2,4-diamino-1,3,5-triazina.
ES2183709A1 (es) Composicion para el control de artropodos.
IL152632A0 (en) Trimethyldecenyl compounds
MXPA05003881A (es) Preparacion de compuestos triazospiro.
SE9901062D0 (sv) Use for conifer sapling protection
RS20050026A (xx) Novi derivati benzohidrazida kao herbicidne i desikantne kompozicije koje ga sadrže
IT1317718B1 (it) Benzilisotiouree ad attivita' fungicida.